PCM
ATRC icon

Pentwater Capital Management’s AtriCure ATRC Stock Holding History

Pentwater Capital Management’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-40,000
Closed -$1.19M – 162
2019
Q2 		$1.19M Hold
40,000
– – 0.01% 128
2019
Q1 		$1.07M Buy
40,000
+15,000
+60% +$456K 0.01% 111
2018
Q4 		$765K Buy
+25,000
New +$779K 0.01% 116

Other funds holding ATRC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

Pentwater Capital Management's ATRC Position: Q3 2019 in Review

Pentwater Capital Management sold out of AtriCure (ATRC) in Q3 2019, closing a stake of 40,000 shares — an estimated $1.19M sold.

Pentwater Capital Management first reported a position in ATRC in Q4 2018 and held it in 3 quarters. The position peaked at $1.19M in Q2 2019. 141 funds tracked by Wall St. Rank hold ATRC as of Q3 2019.

  • Pentwater Capital Management reported no remaining AtriCure position as of Q3 2019 after selling out during the quarter.
  • Pentwater Capital Management sold 40,000 AtriCure shares in Q3 2019, an estimated $1.19M.
  • Pentwater Capital Management first reported a position in AtriCure in Q4 2018 and held it in 3 quarters.
  • Pentwater Capital Management's AtriCure position peaked at $1.19M in Q2 2019.
  • 141 funds tracked by Wall St. Rank held AtriCure as of Q3 2019.

Based on Pentwater Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.